Tech Reporter Virgin Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Reporter Virgin Islands.

Press releases published on March 9, 2026

Mar. 9, 2026

3D Systems Reports Fourth Quarter and Full Year 2025 Financial Results

Indeterminate GlobeNewswire

Mar. 9, 2026

Relmada Therapeutics Reports 12-Month Phase 2 Interim Data for NDV-01 in Non-Muscle Invasive Bladder Cancer

Indeterminate GlobeNewswire

Mar. 9, 2026

Olatorepatide Obesity Treatment Licensed by Regeneron Demonstrates Positive Phase 3 Results in Chinese Patients

Indeterminate GlobeNewswire

Mar. 9, 2026

Constellation Software Inc. Announces Results for the Fourth Quarter and Year Ended December 31, 2025 and Declares Quarterly Dividend

Indeterminate GlobeNewswire

Mar. 9, 2026

Tilray Brands Acquires BrewDog Australia, Establishing Strategic Base to Accelerate Global Beverage and Consumer Products Growth Across the Asia-Pacific Region

Indeterminate GlobeNewswire

Mar. 9, 2026

B2BROKER and Centroid Strengthen Collaboration to Enhance B2TRADER Liquidity and Risk Capabilities

Indeterminate GlobeNewswire

Mar. 9, 2026

Sant Joan de Déu Hospital Ward upgrades energy technology with Schneider Electric KNX Solutions, cutting energy costs by 40%

Indeterminate GlobeNewswire

Mar. 9, 2026

Quest Software Survey Finds That Over 75 Percent of Global Organizations Are Not Testing Identity Disaster Recovery Frequently Enough

Indeterminate GlobeNewswire

Mar. 9, 2026

ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Updates on neffy® (epinephrine nasal spray) Commercialization

Indeterminate GlobeNewswire

Mar. 9, 2026

Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce European Commission Approval of Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa)

Indeterminate GlobeNewswire

Mar. 9, 2026

HUTCHMED Announces Update on Licensed Oncology Product TAZVERIK® in China

Indeterminate GlobeNewswire

Mar. 9, 2026

Smart Communications Appoints David Hamilton as Chairman of the Board

Indeterminate GlobeNewswire

Mar. 9, 2026

Predigy Announces The Launch of "Predigy Edge", a First-of-its-Kind Prediction Market Equivalent Technology, Designed For State Regulated Markets

Indeterminate GlobeNewswire

Mar. 9, 2026

Clearsense Unveils AI Strategy at HIMSS 2026 to Accelerate Cost Optimization and Unlock Archive Intelligence

Indeterminate GlobeNewswire

Mar. 9, 2026

New paper in Frontiers in Medicine reveals first reliable biomarker test for early kidney transplant rejection detection in living-donor recipients

Indeterminate GlobeNewswire

Mar. 9, 2026

kyron.bio Announces Strategic Partnership with Servier to Advance Precision Glycosylation in Antibody Therapeutics

Indeterminate GlobeNewswire

Mar. 9, 2026

Mind-Sync TV Announces Strategic Transition from Web to Global FAST Platforms; Pioneering the "Functional TV" Category in Native 4K

Indeterminate GlobeNewswire

Mar. 9, 2026

AGAMREE® (Vamorolon) – Auf der MDA 2026 vorgestellte Daten bestätigen eine vergleichbare Langzeitwirksamkeit bei einer Behandlungsdauer von bis zu 8 Jahren mit klinisch bedeutsamen Sicherheitsvorteilen bei Duchenne-Muskeldystrophie

Indeterminate GlobeNewswire

Mar. 9, 2026

AGAMREE® (vamorolone) Data Presented at MDA 2026 Confirm Comparable Long-Term Effectiveness for up to 8 Years of Treatment, with Clinically Meaningful Safety Advantages in Duchenne Muscular Dystrophy  

Indeterminate GlobeNewswire

Mar. 9, 2026

Ipsen voluntarily withdraws Tazverik® (tazemetostat) in follicular lymphoma and epithelioid sarcoma

Indeterminate GlobeNewswire